Although the clinical significance of the BDNF Val66Met polymorphism in CRCI and AD is unclear, the literature consistently reports an association between reduced levels of BDNF with CRCI and AD, as well as a protective effect of increasing BDNF in ameliorating these disorders in preclinical models. This evidence concerns the gene BDNF and Alzheimer disease.